Denali Therapeutics Balance Sheet (2017-2026) | DNLI

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter)
394.55M293.48M104.95M155.09M118.61M218.04M68.13M131.97M148.01M127.11M60.57M74.68M90.64M174.96M56.95M141.21M90.96M205.33M387.63M201.53M
Receivables - Net (Quarter)
9.28M3.20M3.40M2.10M2.70M1.90M1.40M1.40M2.17M1.70M1.40M1.90M1.60M1.60M3.93M
Receivables - Other (Quarter)
1.19M1.23M0.36M
Receivables (Quarter)
1.19M1.23M0.36M9.28M3.20M3.40M2.10M2.70M1.90M1.40M1.40M2.17M1.70M1.40M1.90M1.60M1.60M3.93M
Inventory (Quarter)
4.14M
Prepaid Assets (Quarter)
35.39M
Current Assets (Quarter)
753.93M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
49.93M
Long-Term Investments (Quarter)
229.53M
Intangibles (Quarter)
35.25M
Goodwill & Intangibles (Quarter)
35.25M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)
25.82M
Non-Current Assets (Quarter)
404.03M
Assets (Quarter)
1,157.95M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
11.81M
Payables (Quarter)
11.81M
Accumulated Expenses (Quarter)
78.28M
Other Accumulated Expenses (Quarter)
53.16M4.39M
Short term Debt (Quarter)
2.71M1.44M4.39M
Current Leases (Quarter)
5.25M5.45M5.66M5.87M7.07M7.32M6.54M6.77M7.01M7.26M7.51M7.77M8.04M8.31M8.59M8.87M9.16M
Current Deferred Revenue (Quarter)
290.40M1.30M
Total Current Liabilities (Quarter)
90.08M
Non-Current Liabilities
Capital Leases (Quarter)
5.48M
Non-Current Deffered Revenue (Quarter)
31.31M3.40M3.40M3.40M0.48M
Operating Leases (Quarter)
22.03M
Other Non-Current Liabilities (Quarter)
0.70M0.38M0.38M0.38M0.38M0.38M0.38M0.38M0.38M
Total Non-Current Liabilities (Quarter)
436.99M441.49M402.55M407.63M415.92M417.43M442.26M118.53M118.07M122.96M
Total Liabilities (Quarter)
322.78M
Shareholder's Equity
Total Debt (Quarter)
2.71M1.44M4.39M
Common Equity (Quarter)
835.18M
Liabilities and Shareholders Equity (Quarter)
1,157.95M
Retained Earnings (Quarter)
3,142.75M
Treasury Shares (Quarter)
6.60M